Published • loading... • Updated
Medicare’s New GLP-1 Weight Loss Program Is Complicated but Worth It
- Medicare will offer GLP-1 drugs like Wegovy starting July 1, marking the first time these FDA-approved weight loss drugs are accessible through Medicare.
- The Medicare GLP-1 Bridge short-term demonstration program provides these drugs at a low cost of $50 and functions more like a coupon separate from other Medicare offerings,.
- CMS has extended the Bridge program through the end of 2027, maintaining the $50 price tag.
Insights by Ground AI
31 Articles
31 Articles
Older Americans will soon have Medicare access to GLP-1s for weight loss for the first time. Here’s what they need to know.
Starting July 1, Medicare beneficiaries who qualify can get weight-loss drugs for $50 a month. They should consider the side effects and muscle loss.
·United States
Read Full Article
Medicare to cover Ozempic-style weight loss drugs for $50 a month starting July 1: Who qualifies
Millions of Americans on Medicare will have access to prescription weight loss medications for the first time starting July 1 under a new federal program that caps the monthly cost at $50.
·Springfield, United States
Read Full Article
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources31
Leaning Left2Leaning Right8Center14Last UpdatedBias Distribution59% Center
Bias Distribution
- 59% of the sources are Center
59% Center
C 59%
R 33%
Factuality
To view factuality data please Upgrade to Premium
